In breast cancer cells, miR-138 acts as a novel regulator targeting histone methylation transferase to regulate tumor invasion and EMT and cycle-dependent kinase inhibitor-related protein to regulate proliferation and migration of breast cancer cells [24]. Here, PRDM9 is linked to breast carcinoma.